Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the usual study details with an access-restricted notice. This reflects an access/server issue rather than an update to the study content.SummaryDifference18%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdds a line listing '2018 ( U.S. NIH Grant/Contract )' to the page, signaling the funding source. Updates the page revision to v3.6.6, replacing the previous v3.6.5 as part of a minor metadata update.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, reflecting a backend/frontend software update. No study content or data changes are reflected in this modification.SummaryDifference0.0%

- Check69 days agoChange DetectedAdds a new publication citation for the ALLIANCE open-label extension phase (Avihingsanon et al.) and updates the page revision from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision tag updated to v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a new page build. The change represents an updated deployment of the page rather than modification to the study data.SummaryDifference0.0%

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.